Works by Godwin, Andrew K.


Results: 126
    1

    WJMSC‐derived small extracellular vesicle enhance T cell suppression through PD‐L1.

    Published in:
    Journal of Extracellular Vesicles, 2021, v. 10, n. 4, p. 1, doi. 10.1002/jev2.12067
    By:
    • Li, Meizhang;
    • Soder, Rupal;
    • Abhyankar, Sunil;
    • Abdelhakim, Haitham;
    • Braun, Mitchell W.;
    • Trinidad, Camille V.;
    • Pathak, Harsh B.;
    • Pessetto, Ziyan;
    • Deighan, Clayton;
    • Ganguly, Siddhartha;
    • Dawn, Buddhadeb;
    • McGuirk, Joseph;
    • Dunavin, Neil;
    • Godwin, Andrew K.
    Publication type:
    Article
    2
    3

    Mutation detection using a novel plant endonuclease.

    Published in:
    Nucleic Acids Research, 1998, v. 26, n. 20, p. 4597, doi. 10.1093/nar/26.20.4597
    By:
    • Oleykowski, Catherine A.;
    • Bronson Mullins, Colleen R.;
    • Godwin, Andrew K.;
    • Yeung, Anthony T.
    Publication type:
    Article
    4

    Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45960-2
    By:
    • Saeed, Anwaar;
    • Park, Robin;
    • Pathak, Harsh;
    • Al-Bzour, Ayah Nedal;
    • Dai, Junqiang;
    • Phadnis, Milind;
    • Al-Rajabi, Raed;
    • Kasi, Anup;
    • Baranda, Joaquina;
    • Sun, Weijing;
    • Williamson, Stephen;
    • Chiu, Yu-Chiao;
    • Osmanbeyoglu, Hatice Ulku;
    • Madan, Rashna;
    • Abushukair, Hassan;
    • Mulvaney, Kelly;
    • Godwin, Andrew K.;
    • Saeed, Azhar
    Publication type:
    Article
    5

    Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45960-2
    By:
    • Saeed, Anwaar;
    • Park, Robin;
    • Pathak, Harsh;
    • Al-Bzour, Ayah Nedal;
    • Dai, Junqiang;
    • Phadnis, Milind;
    • Al-Rajabi, Raed;
    • Kasi, Anup;
    • Baranda, Joaquina;
    • Sun, Weijing;
    • Williamson, Stephen;
    • Chiu, Yu-Chiao;
    • Osmanbeyoglu, Hatice Ulku;
    • Madan, Rashna;
    • Abushukair, Hassan;
    • Mulvaney, Kelly;
    • Godwin, Andrew K.;
    • Saeed, Azhar
    Publication type:
    Article
    6
    7
    8
    9

    Novel surface targets and serum biomarkers from the ovarian cancer vasculature.

    Published in:
    Cancer Biology & Therapy, 2011, v. 12, n. 3, p. 169, doi. 10.4161/cbt.12.3.16260
    By:
    • Sasaroli, Dimitra;
    • Gimotty, Phyllis A.;
    • Pathak, Harsh B.;
    • Hammond, Rachel;
    • Kougioumtzidou, Eleni;
    • Katsaros, Dionyssis;
    • Buckanovich, Ron;
    • Devarajan, Karthik;
    • Sandaltzopoulos, Raphael;
    • Godwin, Andrew K.;
    • Scholler, Nathalie;
    • Coukos, George
    Publication type:
    Article
    10
    11

    Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.

    Published in:
    British Journal of Cancer, 2023, v. 128, n. 12, p. 2283, doi. 10.1038/s41416-023-02263-5
    By:
    • O'Mahony, Denise G.;
    • Ramus, Susan J.;
    • Southey, Melissa C.;
    • Meagher, Nicola S.;
    • Hadjisavvas, Andreas;
    • John, Esther M.;
    • Hamann, Ute;
    • Imyanitov, Evgeny N.;
    • Andrulis, Irene L.;
    • Sharma, Priyanka;
    • Daly, Mary B.;
    • Hake, Christopher R.;
    • Weitzel, Jeffrey N.;
    • Jakubowska, Anna;
    • Godwin, Andrew K.;
    • Arason, Adalgeir;
    • Bane, Anita;
    • Simard, Jacques;
    • Soucy, Penny;
    • Caligo, Maria A.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19

    Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer.

    Published in:
    Cell Death & Disease, 2024, v. 15, n. 5, p. 1, doi. 10.1038/s41419-024-06717-3
    By:
    • Standing, David;
    • Dandawate, Prasad;
    • Gunewardena, Sumedha;
    • Covarrubias-Zambrano, Obdulia;
    • Roby, Katherine F.;
    • Khabele, Dineo;
    • Jewell, Andrea;
    • Tawfik, Ossama;
    • Bossmann, Stefan H.;
    • Godwin, Andrew K.;
    • Weir, Scott J.;
    • Jensen, Roy A.;
    • Anant, Shrikant
    Publication type:
    Article
    20
    21
    22

    Altered expression of the septin gene, SEPT9, in ovarian neoplasia.

    Published in:
    Journal of Pathology, 2003, v. 201, n. 4, p. 581, doi. 10.1002/path.1484
    By:
    • James F Burrows;
    • Severine Chanduloy;
    • Michael A McIlhatton;
    • Hans Nagar;
    • Karen Yeates;
    • Paul Donaghy;
    • John Price;
    • Andrew K Godwin;
    • Patrick G Johnston;
    • SE Hilary Russell
    Publication type:
    Article
    23
    24

    Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00535-0
    By:
    • Fanucci, Kristina A.;
    • Bai, Yalai;
    • Pelekanou, Vasiliki;
    • Nahleh, Zeina A.;
    • Shafi, Saba;
    • Burela, Sneha;
    • Barlow, William E.;
    • Sharma, Priyanka;
    • Thompson, Alastair M.;
    • Godwin, Andrew K.;
    • Rimm, David L.;
    • Hortobagyi, Gabriel N.;
    • Liu, Yihan;
    • Wang, Leona;
    • Wei, Wei;
    • Pusztai, Lajos;
    • Blenman, Kim R. M.
    Publication type:
    Article
    25
    26

    Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00448-4
    By:
    • Yoder, Rachel;
    • Kimler, Bruce F.;
    • Staley, Joshua M.;
    • Schwensen, Kelsey;
    • Wang, Yen Y.;
    • Finke, Karissa;
    • O'Dea, Anne;
    • Nye, Lauren;
    • Elia, Manana;
    • Crane, Gregory;
    • McKittrick, Richard;
    • Pluenneke, Robert;
    • Madhusudhana, Sheshadri;
    • Beck, Larry;
    • Shrestha, Anuj;
    • Corum, Larry;
    • Marsico, Mark;
    • Stecklein, Shane R.;
    • Godwin, Andrew K.;
    • Khan, Qamar J.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Expression of constitutively activated EGFRvlll in non-small cell lung cancer.

    Published in:
    Cancer Science, 2003, v. 94, n. 1, p. 50, doi. 10.1111/j.1349-7006.2003.tb01351.x
    By:
    • Okamoto, Isamu;
    • Kenyon, Lawrence C.;
    • Emlet, David R.;
    • Mori, Takeshi;
    • Sasaki, Ji-ichiro;
    • Hirosako, Susumu;
    • Ichikawa, Yasuko;
    • Kishi, Hiroto;
    • Godwin, Andrew K.;
    • Yoshioka, Masakazu;
    • Suga, Moritaka;
    • Matsumoto, Mitsuhiro;
    • Wong, Albert J.
    Publication type:
    Article
    41
    42
    43
    44

    Comparison of DNA- and RNA-Based Methods for Detection of Truncating BRCA1 Mutations.

    Published in:
    Human Mutation, 2002, v. 20, n. 1, p. 65, doi. 10.1002/humu.10097
    By:
    • Andrulis, Irene L.;
    • Anton-Culver, Hoda;
    • Beck, Jeanne;
    • Bove, Betsy;
    • Boyd, Jeff;
    • Buys, Saundra;
    • Godwin, Andrew K.;
    • Hopper, John L.;
    • Li, Frederick;
    • Neuhausen, Susan L.;
    • Ozcelik, Hilmi;
    • Peel, David;
    • Santella, Regina M.;
    • Southey, Melissa C.;
    • van Orsouw, Nathalie J.;
    • Venter, Deon J.;
    • Vijg, Jan;
    • Whittemore, Alice S.
    Publication type:
    Article
    45
    46
    47

    Proteomic Profiling of Fallopian Tube-Derived Extracellular Vesicles Using a Microfluidic Tissue-on-Chip System.

    Published in:
    Bioengineering (Basel), 2023, v. 10, n. 4, p. 423, doi. 10.3390/bioengineering10040423
    By:
    • Zha, Didi;
    • Rayamajhi, Sagar;
    • Sipes, Jared;
    • Russo, Angela;
    • Pathak, Harsh B.;
    • Li, Kailiang;
    • Sardiu, Mihaela E.;
    • Bantis, Leonidas E.;
    • Mitra, Amrita;
    • Puri, Rajni V.;
    • Trinidad, Camille V.;
    • Cain, Brian P.;
    • Isenberg, Brett C.;
    • Coppeta, Jonathan;
    • MacLaughlan, Shannon;
    • Godwin, Andrew K.;
    • Burdette, Joanna E.
    Publication type:
    Article
    48
    49
    50

    Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).

    Published in:
    Biomarkers, 2023, v. 28, n. 3, p. 313, doi. 10.1080/1354750X.2023.2168063
    By:
    • Bergqvist, Mattias;
    • Nordmark, Adrian;
    • Williams, Amy;
    • Paoletti, Costanza;
    • Barlow, William;
    • Cobain, Erin F.;
    • Mehta, Rita S.;
    • Gralow, Julie R.;
    • Hortobagyi, Gabriel N.;
    • Albain, Kathy S.;
    • Pusztai, Lajos;
    • Sharma, Priyanka;
    • Godwin, Andrew K.;
    • Thompson, Alastair M.;
    • Hayes, Daniel F.;
    • Rae, James M.
    Publication type:
    Article